Croda International Plc (LON:CRDA) has confirmed that, following approval from the US regulatory authorities, it has now successfully completed the acquisition of Avanti Polar Lipids, Inc., a leader in drug delivery systems for next generation pharmaceuticals.
For further information see the announcement of the acquisition signing dated 6 July 2020.
Croda International is the speciality chemical company that creates high performance ingredients and technologies relied upon by industries and consumers globally. More at www.croda.com.
